News
Caddo Parish Public Schools students achieved notable gains in math while sustaining growth in English and science, and ...
The state's Superintendent of Education said the latest LEAP results demonstrate "sustained growth" for Louisiana kids.
Twenty years ago, cognitive psychologist Elizabeth Spelke took a strong position in an ongoing public debate. "There are no ...
The upgraded price target reflects confidence in Rocket Lab’s ability to leverage its $1.07 billion backlog and projected 31–33% revenue growth in FY2025, despite the stock trading at a premium.
Where Target could be in a year It doesn't look like things are going to get much easier for Target in the near future, and investors shouldn't expect a huge rebound over the next 12 months. There ...
The search for more cuts comes as GOP senators are looking at all areas where they can go beyond the House’s $1.6 trillion in cuts. But the push is being complicated by the fact that some Senate ...
This study not only reveals the stealth tactics HSV-1 uses to persist in the brain but also introduces a new therapeutic concept—targeting viral immune evasion rather than the virus itself.
SHANGHAI & CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...
Hosted on MSN1mon
Where Will Rocket Lab Be in 1 Year? - MSNIf Rocket Lab hits that mark, I could consider calling the stock a buy five years from now. But at today's prices, it's not a buy, and I expect the stock price to be lower in one year.
Analysts had expected $1.64 and $24.34 billion, respectively, per Visible Alpha. However, Target's GAAP EPS of $2.27, which includes the gains from litigation settlements, topped the $1.64 estimate.
Last year, scientists warned that three individual years where average temperatures remained above 1.5°C would mean the Paris Agreement target is lost. Similarly, a paper published earlier this ...
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice. eBioMedicine, 2025; 105734 DOI: 10.1016/j.ebiom.2025.105734 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results